WPI 3704 (Armodafinil 200 mg)
Pill with imprint WPI 3704 is White, Capsule-shape and has been identified as Armodafinil 200 mg. It is supplied by Watson Laboratories, Inc..
Armodafinil is used in the treatment of narcolepsy; obstructive sleep apnea/hypopnea syndrome; shift work sleep disorder; adhd; chronic fatigue syndrome (and more), and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Armodafinil 200 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for WPI 3704
Armodafinil
- Imprint:
- WPI 3704
- Strength:
- 200 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 4 - Some potential for abuse
- Labeler / Supplier:
- Watson Laboratories, Inc.
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
croscarmellose sodium
hypromelloses
magnesium stearate
corn starch
Note: Inactive ingredients may vary.
More about armodafinil
- Armodafinil Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 293 Reviews
- Drug class: CNS stimulants
Consumer resources
Other brands: Nuvigil
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
